Rivera, F., Benavides, M., Gallego, J., Guillen-Ponce, C., Lopez-Martin, J., & Küng, M. (2019). Tumor treating fields in combination with gemcitabine or gemcitabine plus nab-paclitaxel in pancreatic cancer: Results of the PANOVA phase 2 study. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 19(1), 64-72. https://doi.org/10.1016/j.pan.2018.10.004
Citácia podle Chicago (17th ed.)Rivera, Fernando, Manuel Benavides, Javier Gallego, Carmen Guillen-Ponce, José Lopez-Martin, a Marc Küng. "Tumor Treating Fields in Combination with Gemcitabine or Gemcitabine Plus Nab-paclitaxel in Pancreatic Cancer: Results of the PANOVA Phase 2 Study." Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.] 19, no. 1 (2019): 64-72. https://doi.org/10.1016/j.pan.2018.10.004.
Citácia podľa MLA (8th ed.)Rivera, Fernando, et al. "Tumor Treating Fields in Combination with Gemcitabine or Gemcitabine Plus Nab-paclitaxel in Pancreatic Cancer: Results of the PANOVA Phase 2 Study." Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.], vol. 19, no. 1, 2019, pp. 64-72, https://doi.org/10.1016/j.pan.2018.10.004.